Skip to main content
. 2018 Dec 17;80(5):540–546. doi: 10.1055/s-0038-1676628

Fig. 2.

Fig. 2

Axial T1-weighted postgadolinium magnetic resonance imaging demonstrating left vestibular schwannoma extending into the cerebellopontine angle prior to bevacizumab therapy ( A ) and at the end of bevacizumab therapy ( B ). Tumor volume at the end of bevacizumab was 49.5% of the starting volume.